安大略省年轻人肥厚型心肌病相关心脏性猝死研究
结果显示明确HCM相关SCD年发病率为0.31/1000 HCM人年(95%CI 0.24-0.44),多数SCD发生在既往未诊断者(70%),且多发生于静息(64.8%)或轻度活动(18.5%)时。
要点
- HCM相关SCD年发病率低于既往报道,明确病例为0.31/1000 HCM人年。
- 70%的SCD发生在既往未诊断HCM的个体。
- 多数SCD发生于静息或轻度活动时,运动相关少见。
核心结论
- 10至45岁一般人群中HCM相关SCD发病率显著低于既往报道。
- 大多数SCD发生在既往未诊断的个体。
- SCD与运动相关性不高。
研究设计与样本
- 通过典型宏观和微观特征确认明确HCM相关SCD,有临床诊断但未尸检者为可能病例,有典型特征但无肌纤维紊乱为疑似病例。
- 使用安大略省所有植入机构的ICD注册数据识别10至45岁HCM患者的二级预防新植入及一级预防植入和适当电击。
主要发现
- 共识别明确、可能和疑似HCM相关SCD病例分别为44例、3例和6例。
- 明确HCM相关SCD年发病率为0.31/1000 HCM人年(95%CI 0.24-0.44)。
- 明确或可能HCM相关SCD年发病率为0.33/1000 HCM人年(95%CI 0.34-0.62)。
- HCM相关SCD加复苏成功心脏骤停及HCM相关危及生命心律失常(SCD、复苏成功心脏骤停和适当ICD电击)的年发病率为0.84/1000 HCM人年(95%CI 0.70-1.0)。
临床怎么用
- 在一般人群中,HCM相关SCD的实际风险较低,临床评估时应结合人群基础风险。
- 多数SCD发生在未诊断个体,提示早期识别和诊断HCM可能有助于预防。
- 运动相关SCD比例较低,但具体运动建议需结合个体风险评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hypertrophic cardiomyopathy (HCM) is considered a leading cause of sudden cardiac death (SCD) in younger people. The incidence of HCM-related SCD and its relationship to exercise have not been well studied in large comprehensive studies outside of tertiary care settings. This study sought to estimate the incidence of HCM-related SCD and its association with exercise in a large unselected population. METHODS: Using the Office of the Chief Coroner of Ontario database encompassing all deaths attended by the coroner, we identified all HCM-related SCDs in individuals 10 to 45 years of age between 2005 and 2016 (70 million person-years). Confirmation of HCM was based on typical macroscopic and microscopic features (definite HCM-related SCD). Sudden deaths with a prior clinical diagnosis of HCM but no autopsy were considered probable HCM-related SCDs. Cases with typical features but no myofiber disarray were considered possible HCM. The completeness of data was verified in a subset of patients in the Toronto area with the use of a registry of all emergency medical services-attended cardiac arrests, with an autopsy rate of 94%. To estimate the number of HCM-related aborted cardiac arrests and lives potentially saved by implantable cardioverter-defibrillators, all de novo implantations for secondary prevention and all implantations and appropriate shocks for primary prevention in patients with HCM 10 to 45 years of age, respectively, were identified with the use of a registry containing data on implantable cardioverter-defibrillator implantations from all implanting sites throughout Ontario. RESULTS: Forty-four, 3, and 6 cases of definite, probable, and possible HCM-related SCDs, respectively, were identified, corresponding to estimated annual incidence rates of 0.31 per 1000 HCM person-years (95% CI, 0.24-0.44) for definite HCM-related SCD, 0.33 per 1000 HCM person-years (95% CI, 0.34-0.62) for definite or probable HCM-related SCD, and 0.39 per 1000 HCM person-years (95% CI, 0.28-0.49) for definite, probable, or possible HCM-related SCD (estimated 140 740 HCM person-years of observation). The estimated annual incidence rate for HCM-related SCD plus aborted cardiac arrest and HCM-related life-threatening arrhythmia (SCD, aborted cardiac arrest, and appropriate implantable cardioverter-defibrillator shocks) was 0.84 per 1000 HCM person-years (95% CI, 0.70-1.0). The majority (70%) of SCDs occurred in previously undiagnosed individuals. Most SCDs occurred during rest (64.8%) or light activity (18.5%). CONCLUSIONS: The incidence of HCM-related SCD in the general population 10 to 45 years of age is substantially lower than previously reported, with most cases occurring in previously undiagnosed individuals. SCDs are infrequently related to exercise.
引用
- Weissler-Snir A, Allan K, Cunningham K, et al. Hypertrophic Cardiomyopathy-Related Sudden Cardiac Death in Young People in Ontario. Circulation. 2019. PMID: 31630535. doi:10.1161/CIRCULATIONAHA.119.040271
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。